Cripto favours chondrocyte hypertrophy via TGF-beta SMAD1/5 signaling in experimental osteoarthritis

Cripto favours chondrocyte hypertrophy via TGF-beta SMAD1/5 signaling in experimental osteoarthritis

Bibliographic Details
Main Authors:	Gonzalo Sanchez-Duffhues, Amaya Garcia de Vinuesa Antuñano, Esmeralda Blaney-Davidson, Arjan van Caam, Kirsten Lodder, Yolande Ramos, Margreet Kloppenburg, Ingrid Meulenbelt, Peter van der Kraan, Marie-José Goumans, Peter ten Dijke
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Bone Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352187221002989

Similar Items

TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity
by: Arjan van Caam, et al.
Published: (2017-05-01)

Osteoarthritis-Related Inflammation Blocks TGF-β’s Protective Effect on Chondrocyte Hypertrophy via (de)Phosphorylation of the SMAD2/3 Linker Region
by: Nathalie Thielen, et al.
Published: (2021-07-01)

Identification of Transcription Factors Responsible for a Transforming Growth Factor-β-Driven Hypertrophy-like Phenotype in Human Osteoarthritic Chondrocytes
by: Nathalie G. M. Thielen, et al.
Published: (2022-04-01)

Smad signal transduction : Smads in proliferation, differentiation and disease /
by: Dijke, Peter Ten, et al.
Published: (2006)

Romances Cripto-Judaicos Portugueses
by: Manuel da Costa Fontes
Published: (2022-12-01)

Growth factors that drive aggrecan synthesis in healthy articular cartilage. Role for transforming growth factor-β?
by: Peter M. van der Kraan, et al.
Published: (2024-06-01)

Transcription Factors in Cartilage Homeostasis and Osteoarthritis
by: Margot Neefjes, et al.
Published: (2020-09-01)

TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
by: Jin Ma, et al.
Published: (2020-04-01)

Oncofetal Protein CRIPTO Is Involved in Wound Healing and Fibrogenesis in the Regenerating Liver and Is Associated with the Initial Stages of Cardiac Fibrosis
by: Sofia Karkampouna, et al.
Published: (2021-11-01)

Autoregulation and heterogeneity in expression of human Cripto-1.
by: Pojul Loying, et al.
Published: (2015-01-01)

Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis
by: Theodoros-Ioannis Papadimitriou, et al.
Published: (2022-01-01)

TGFβ/BMP Signaling Pathway in Cartilage Homeostasis
by: Nathalie G.M. Thielen, et al.
Published: (2019-08-01)

Smad7 and protein phosphatase 1α are critical determinants in the duration of TGF-β/ALK1 signaling in endothelial cells
by: Heldin Carl-Henrik, et al.
Published: (2006-03-01)

Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal
by: David W. Freeman, et al.
Published: (2021-09-01)

Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma
by: Li Xiangping, et al.
Published: (2009-09-01)

Smad4 regulates growth plate matrix production and chondrocyte polarity
by: Amanda T. Whitaker, et al.
Published: (2017-03-01)

Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy
by: Hiroko Ishii, et al.
Published: (2021-05-01)

O cristão-novo Bento Teixeira: cripto-judaismo no Brasil Colônia
by: Sônia Aparecida Siqueira
Published: (1972-06-01)

Biological and Clinicopathological Significance of Cripto-1 Expression in the Progression of Human ESCC
by: Reihaneh Alsadat Mahmoudian, et al.
Published: (2017-05-01)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
by: Chunxiao Hu, et al.
Published: (2021-08-01)

CRIPTO/GRP78 Signaling Maintains Fetal and Adult Mammary Stem Cells Ex Vivo
by: Benjamin T. Spike, et al.
Published: (2014-04-01)

Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva
by: Francesc Ventura, et al.
Published: (2021-02-01)

SMAD6-deficiency in human genetic disorders
by: Ilse Luyckx, et al.
Published: (2022-11-01)

New Insights into Cancer Targeted Therapy: Nodal and Cripto-1 as Attractive Candidates
by: Paola Arboretto, et al.
Published: (2021-07-01)

Criptos activo para la intermediación e inversión financiera en Colombia
by: José Alfonso Mendoza Gallego, et al.
Published: (2021-09-01)

Expression and prognostic value of Cripto‐1 in early non‐small cell lung cancer
by: Jian Zhong, et al.
Published: (2023-12-01)

Conditional Cripto overexpression in satellite cells promotes myogenic commitment and enhances early regeneration
by: Carolina ePrezioso, et al.
Published: (2015-05-01)

In vivo and in vitro study of co-expression of LMP1 and Cripto-1 in nasopharyngeal carcinoma
by: Qing Ye, et al.
Published: (2020-09-01)

A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological Roles
by: Elisa Rodrigues Sousa, et al.
Published: (2020-06-01)

Challenges and opportunities for drug repositioning in Fibrodysplasia ossificans progressiva
by: Ventura, F, et al.
Published: (2021)

A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth
by: Hiroko Ishii, et al.
Published: (2021-02-01)

Elevated serum Cripto‐1 and VEGF levels in patients with non‐small cell lung cancer
by: Chunhua Xu, et al.
Published: (2022-08-01)

Cripto is essential to capture mouse epiblast stem cell and human embryonic stem cell pluripotency
by: Alessandro Fiorenzano, et al.
Published: (2016-09-01)

CRIPTO antagonist ALK4L75A-Fc inhibits breast cancer cell plasticity and adaptation to stress
by: Ozlen Balcioglu, et al.
Published: (2020-11-01)

Environmental adversity and uncertainty favour cooperation
by: Lazarus John, et al.
Published: (2007-11-01)

Strontium Regulates the Proliferation and Differentiation of Isolated Primary Bovine Chondrocytes via the TGFβ/SMAD Pathway
by: Siqi Liu, et al.
Published: (2022-05-01)

Circulating MicroRNAs Highly Correlate to Expression of Cartilage Genes Potentially Reflecting OA Susceptibility—Towards Identification of Applicable Early OA Biomarkers
by: Yolande F. M. Ramos, et al.
Published: (2021-09-01)

Cripto Is Targeted by miR-1a-3p in a Mouse Model of Heart Development
by: Tiziana Angrisano, et al.
Published: (2023-07-01)

Cripto-1 as a Key Factor in Tumor Progression, Epithelial to Mesenchymal Transition and Cancer Stem Cells
by: Hilal Arnouk, et al.
Published: (2021-08-01)

CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer
by: Federica Francescangeli, et al.
Published: (2022-06-01)